Overview
- Description
The company develops first-in-class therapies for neurodegenerative diseases using homeoprotein-based treatments, with lead candidates targeting ALS, Parkinson’s, and retinal disorders.
- Website
- Country
- France
- Sector
- Health Biotechnology